EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Invasive Biomarkers for Assessing Liver Fibrosis in Biliary Atresia: A Literature Review

Gabriel Bența iD, Alina Grama, Alexandra Mititelu iD, Alexandru-Ștefan Niculae iD, Tudor Lucian Pop iD

International Journal of Molecular Sciences · 11.06.2026 · 27 (12) · 5295

DOI: 10.3390/ijms27125295 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 11.06.2026. Verfasst von Gabriel Bența und 4 weiteren Autor:innen. Beteiligte Einrichtung: Second Pediatric Discipline, Department of Mother and Child, Iuliu Haţieganu University of Medicine and Pharmacy, 400177 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Biliary Atresia, Biomarkers, Liver Cirrhosis. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerul Investițiilor si Proiectelor Europene, “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Biliary atresia (BA) is the leading indication for pediatric liver transplantation. In the absence of surgical treatment, BA progresses rapidly toward hepatic fibrosis and cirrhosis. Although liver biopsy remains the gold standard for histological evaluation, its utility is limited by invasiveness, associated risks, and sampling variability. These limitations have spurred the development and validation of noninvasive tools to evaluate liver fibrosis in this patient population. Multiple imaging techniques have been developed to assess liver fibrosis and cirrhosis. In recent years, additional BA-related biomarkers have been identified, showing significant potential for diagnosis, assessment of fibrosis severity, and prediction of native liver survival outcomes. This article reviews the roles and potential clinical applications of the following biomarkers: matrix metalloproteinase-7 (MMP-7), fibroblast growth factor 19 (FGF-19), interleukin-33 (IL-33), clusterin, and osteopontin. Further research is needed to confirm the utility of these prognostic biomarkers in predicting and improving outcomes in BA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biliary AtresiaBiomarkersLiver CirrhosisHumansPrognosis

Stichwörter der Autor:innen

biliary atresiafibrosisnon-invasive biomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Second Pediatric Discipline, Department of Mother and Child, Iuliu Haţieganu University of Medicine and Pharmacy, 400177 Cluj-Napoca, Romania.
  • Second Pediatric Clinic, Center of Expertise in Pediatric Rare Liver Diseases, Emergency Clinical Hospital for Children, 400177 Cluj-Napoca, Romania.

ORCID-Profile: Gabriel Bența, Alexandra Mititelu, Alexandru-Ștefan Niculae, Tudor Lucian Pop

Förderung

  • Ministerul Investițiilor si Proiectelor Europene
  • “Iuliu Hațieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania

Zitieren

APA

Bența, G., Grama, A., Mititelu, A., Niculae, A. Ș., & Pop, T. L. (2026). Non-Invasive Biomarkers for Assessing Liver Fibrosis in Biliary Atresia: A Literature Review. International Journal of Molecular Sciences, 27(12), 5295. https://doi.org/10.3390/ijms27125295

Vancouver

Bența G, Grama A, Mititelu A, Niculae AȘ, Pop TL. Non-Invasive Biomarkers for Assessing Liver Fibrosis in Biliary Atresia: A Literature Review. International Journal of Molecular Sciences. 2026;27(12):5295. doi:10.3390/ijms27125295

BibTeX
@article{Bena2026,
  author = {Bența, Gabriel and Grama, Alina and Mititelu, Alexandra and Niculae, Alexandru-Ștefan and Pop, Tudor Lucian},
  title = {Non-Invasive Biomarkers for Assessing Liver Fibrosis in Biliary Atresia: A Literature Review},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {12},
  pages = {5295},
  doi = {10.3390/ijms27125295}
}
Kostenlos starten →